Resources
Genesys achieves ISO/IEC 42001:2023 certification for responsible AI governance
Artificial intelligence (AI) is reshaping the customer experience in remarkable ways. What began as simple automation is evolving into systems that can learn, reason,...
How User-Generated Content is Transforming Pharma Insights on the Patient Experience
Social comments show how patients, caregivers, and HCPs interpret your content in real time. They reveal where questions keep surfacing, where misinformation starts to...
Closing the Loop: How B-Stock’s B2B Resale Drives Circularity
The scale of returned and excess inventory continues to grow — and so does the pressure to reduce waste while maintaining recovery.At the same...
Optimizing Mixing Efficiency 5 Strategies for Industrial Manufacturers
The manufacturing landscape is evolving rapidly, marked by ever-increasing competition and consumer demands, unpredictable supply chain disruptions, and the persistent challenge of employee turnover....
A comprehensive guide to Genesys Cloud AI
Gain the competitive edge you need with Genesys Cloud AICustomer and employee expectations are changing. To remain competitive, businesses need the ability to innovate...
Enhancing security posture with SentinelOne and Cloudflare One
The integration between Cloudflare One and SentinelOne provides organizations with a comprehensive security solution that combines endpoint protection with Zero Trust Network Access. This...
Improve your pharmaceutical emulsification process with an ultra-high shear mixer. (May 2026)
Consider upgrading your emulsification process to an ultra-high shear mixer to obtain finer droplet sizes and handle higher viscosity emulsions.
Download Now
Sovereignty as Strategy: Building Trust, Control and Innovation in the AI Era
Digital sovereignty is reshaping how organisations approach data, infrastructure, and AI in an increasingly complex regulatory and geopolitical landscape. No longer a compliance exercise,...
Mixing Technologies in the Pharmaceutical and Medical Industries (May 2026)
This white paper presents an overview of mixing technologies implemented across many of today’s highly competitive pharmaceutical and medical industries, as well as new...
The future-ready foundation: What CIOs need to support innovation and compliance efforts
A significant number of organizations are operating in a ""hybrid by accident"" reality. Unintentionally fragmented data environments and siloed tools have left CIOs without...
Taming the Complexity of AI Data Readiness
Most enterprises are hindered by "legacy debt" and siloed data, leaving them with massive datasets that function merely as expensive storage rather than a...
The Power of Real World Data to Study Women’s Health at Scale
Despite having a longer life expectancy compared to men, women in the U.S. generally have a higher prevalence of chronic conditions. Complicating matters, women’s...
HIPAA Security Rule 2026: The Law Firm Compliance Checklist
The 2025 HIPAA Security Rule updates take effect in 2026 and introduce stricter technical safeguard requirements for any entity that handles electronic protected health...
From Chaos to Control Why ‘Hybrid by Design’ Is the Future of Enterprise Data Strategy
Hybrid cloud was intended to be a strategy, but for many, it became ""hybrid by accident""—a chaotic mix of silos, rising costs, and compliance...
Accelerating early RWE exploration without increasing analytic burden
How can lean life sciences teams generate credible real-world evidence without slowing down? This case study shows how a mid-size organization used HealthVerity eXOs...
The Data Readiness Index: Understanding the Foundations for Successful AI
As AI tools and data-driven strategies reshape the competitive landscape, organizations are racing to turn AI-powered aspirations into measurable results. But speed without a...
Validating HealthVerity eXOs: An agentic AI platform for real-world evidence
Can you trust AI to generate real-world evidence? This validation study puts HealthVerity eXOs to the test using the ISPOR ELEVATE-GenAI framework, demonstrating high...
The RWE Backlog Problem
Emerging pharma teams face growing pressure to answer critical real-world evidence questions—without the resources of large organizations. The RWE Backlog Problem explores how limited...
Smarter Decisions, Stronger Medicines: The Role of Advanced Analytics
Pharmaceutical and biopharmaceutical companies are navigating tightening regulations, rising R&D costs, and intensifying competition, prompting a comprehensive reassessment of their production systems. By leveraging...
PFAS in Our Environment: Exploring Effects, Widespread Contamination, and Detection Methods (May 2026)
PFAS are long-lasting chemical compounds used in many industrial and consumer applications, now widely detected in the environment and linked to potential health concerns....
PFAS The Hidden Threat Infographic
PFAS, or “forever chemicals,” are persistent synthetic compounds that accumulate in the environment and human body, increasingly entering the food chain through water, soil,...